Michael F. Huang
Sr. VP of Clinical Development · SOLENO THERAPEUTICS INC
- 2026
- May 18, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael F. Huang files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Meredith Manning - $229K in SLNO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael F. Huang?
Michael F. Huang is a corporate insider, tracked as Sr. VP of Clinical Development of SOLENO THERAPEUTICS INC (SLNO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Michael F. Huang last file a Form 4?
The most recent primary Form 4 on record is dated 18 May 2026, one of 3 filings going back to 2026.
Has Michael F. Huang been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($200K) across all tracked filings.
